Global Cell Signalling Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Cell Signalling Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Signalling Type (Endocrine Signalling, Paracrine Signalling, Autocrine Signalling, Synaptic Signalling, and Other Signalling Products), Product (Instruments, and Consumables), Technology (Flow Cytometry, Mass Spectrometry, Western Blotting, ELISA, and Other Technologies), Pathway (AKT Signalling Pathway, AMPK Signalling Pathway, ErbB/HER Signalling Pathway, and Other Signalling Pathways), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Cell Signalling Market was valued at USD 3,836.8 million in 2023 and is expected to reach USD 6,494.4 million by 2031 while growing at a CAGR of 6.8% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global cell signalling market growth. Cell signalling, or cellular communication, is the intricate communication system between cells in multicellular organisms. Signalling pathways enable cells to respond to their environment, coordinate activities, and regulate physiological processes, playing a crucial role in maintaining tissue and organ homeostasis for proper organism functioning.
The cell signalling market is expected to experience significant growth in the future, driven by advancements in cell biology, molecular research, and increasing demand for personalized medicine. Despite these positive factors, obstacles such as high research and development costs, as well as ethical concerns and regulatory compliance, may impede market expansion.
Furthermore, the global cell signalling industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Signalling Type Analysis
The Global Cell Signalling Market is segmented among Endocrine Signalling, Paracrine Signalling, Autocrine Signalling, Synaptic Signalling, and Other Signalling Products, based on Signalling Type. In 2023, Endocrine Signalling accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Product Analysis
The Global Cell Signalling Market is segmented among Instruments, and Consumables, based on Product. In 2023, Consumables accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Cell Signalling Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signalling Technology Inc., Danaher Corporation (Beckman Coulter Inc.), Merck KGaA, PerkinElmer Inc., Promega Corporation, Qiagen NV, Thermo Fischer Scientific Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Cell Signalling Market Dynamics
Drivers
Restraints
Opportunity
4. Global Cell Signalling Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Cell Signalling Market Segmentation, By Signalling Type
Global Cell Signalling Market Share Analysis, By Signalling Type
Global Cell Signalling Market Growth Analysis, By Signalling Type
Global Cell Signalling Market Trends, By Signalling Type
o Endocrine Signalling
o Paracrine Signalling
o Autocrine Signalling
o Synaptic Signalling
o Other Signalling Types
6. Global Cell Signalling Market Segmentation, By Product
Global Cell Signalling Market Share Analysis, By Product
Global Cell Signalling Market Growth Analysis, By Product
Global Cell Signalling Market Trends, By Product
o Instruments
o Consumables
7. Global Cell Signalling Market Segmentation, By Technology
Global Cell Signalling Market Share Analysis, By Technology
Global Cell Signalling Market Growth Analysis, By Technology
Global Cell Signalling Market Trends, By Technology
o Flow Cytometry
o Mass Spectrometry
o Western Blotting
o ELISA
o Other Technologies
8. Global Cell Signalling Market Segmentation, By Pathway
Global Cell Signalling Market Share Analysis, By Pathway
Global Cell Signalling Market Growth Analysis, By Pathway
Global Cell Signalling Market Trends, By Pathway
o AKT Signalling Pathway
o AMPK Signalling Pathway
o ErbB/HER Signalling Pathway
o Other Signalling Pathways
9. Global Cell Signalling Market Segmentation, By Region
Global Cell Signalling Market Share Analysis, By Region
Global Cell Signalling Market Growth Analysis, By Region
Global Cell Signalling Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
10. Competitive Landscape
Becton, Dickinson & Company*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Bio-Rad Laboratories Inc.
Bio-Techne Corporation
Cell Signalling Technology Inc.
Danaher Corporation (Beckman Coulter Inc.)
Merck KGaA
PerkinElmer Inc.
Promega Corporation
Qiagen NV
Thermo Fischer Scientific Inc.
*Similar analysis will be provided for each company listed above.
